orforglipron and retatrutide PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Retatrutide vs Foundayo (Orforglipron): Injection
Description
While injections tend to be more potent, oral medications provide an easier option for those who prefer not to inject themselves

GLP-1s often cause nausea or diarrhea, leading to baseline dehydration

American Psychologist, 62(3), 220-233

We on the front lines are seeing the very real risks of obesity right now, and we should not deprive patients of medications that can reduce or even remove those risks entirely, she says

Experimental research has explored how glucagon receptor activation interacts with other metabolic pathways when stimulated concurrently

Rare but serious risks, such as pancreatitis, must also be considered
